Stellate Ganglion Block for the Treatment of COVID-19−Induced Parosmia
About this episode
This episode features an interview with the authors of a clinical trial on the use of stellate ganglion block for treating COVID-19-induced parosmia.
Interview with Nyssa Fox Farrell, MD, and Lara W. Crock, MD, PhD, MSCI, authors of Stellate Ganglion Block for the Treatment of COVID-19−Induced Parosmia: A Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Stellate Ganglion Block for the Treatment of COVID-19−Induced Parosmia
More episodes of JAMA Otolaryngology–Head & Neck Surgery Author Interviews
- Federal Funding in Otolaryngology–Head and Neck Surgery
- Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma
- Why Hearing Health Must Be Part of Voice Biomarker Research
- Biofeedback vs Respiratory Retraining for Inducible Laryngeal Obstruction
- Evaluation of Practice Patterns for 6-Sinus Balloon Sinus Dilation
- The JAMA Otolaryngology-Head & Neck Surgery Editorial Fellowship Experience
Explore listener stats, chart rankings, contacts and more on the JAMA Otolaryngology–Head & Neck Surgery Author Interviews podcast page.